SABESTOMIG
UNII X79QP2R2CZ

Substance Identification & Data

This profile provides standardized clinical and technical data for Sabestomig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X79QP2R2CZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2648346-74-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
X79QP2R2CZ
CAS Registry Number
2648346-74-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SABESTOMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12457
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sabestomig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SABESTOMIG

Common Names & Synonyms

IMMUNOGLOBULIN G1 (239-PHENYLALANINE,240-GLUTAMIC ACID,336-SERINE,354-CYSTEINE,371-SERINE,373-ALANINE,412-VALINE), BISPECIFIC, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS CLONE LO115 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN-MUS MUSCULUS CLONE LO115 .KAPPA.-CHAIN, BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (131-CYSTEINE,225-CYSTEINE,239-PHENYLALANINE,240-GLUTAMIC ACID,336-SERINE,359-CYSTEINE,371-TRYPTOPHAN) ANTI-(HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN-CONTAINING PROTEIN 3) (HUMAN-MUS MUSCULUS CLONE O13-1 .GAMMA.1-CHAIN) DISULFIDE WITH (123-CYSTEINE,213-VALINE) HUMAN-MUS MUSCULUS CLONE O13-1 .LAMBDA.-CHAIN
IMMUNOGLOBULIN G1-KAPPA/LAMBDA, ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD1, PD-1, CD279) AND HAVCR2 (HEPATITIS A VIRUS CELLULAR RECEPTOR 2, T CELL IMMUNOGLOBULIN AND MUCIN DOMAINS FAMILY MEMBER 3, TIM3, TIM-3, TIMD3, CD366)), HUMANIZED AND HOMO SAPIENS MONOCLONAL ANTIBODY, BISPECIFIC, BIVALENT
SABESTOMIG [INN]